Sleep and Type 2 Diabetes: Why Sleep Quality Belongs in a Whole-Person Care Plan
When people talk about managing type 2 diabetes, the conversation usually turns to food, medications, physical activity, or glucose monitoring. Sleep is often left out—despite the fact that poor sleep can affect energy, mood, appetite, activity, and the ability to follow through on every other part of a care plan. A new study adds to […]
The Muscle Molecule Released With Exercise: What L-BAIBA Research Means for Type 2 Diabetes Care
When people hear that exercise is useful for type 2 diabetes, they may think first about calories, weight loss, or “earning” food. That framing misses much of the biology—and it can make movement feel like a punishment. Muscles are active metabolic organs. When they contract, they use glucose, communicate with other tissues, adapt to training, […]
Type 2 Diabetes and Brain Health: What Recent Studies on Blood Sugar and Medications Can—and Cannot—Tell Us
Type 2 diabetes is often discussed through blood glucose, weight, A1c, blood pressure, or cholesterol. Those measures matter. But people living with diabetes are also asking a broader question: What does metabolic health mean for the brain over time? Brain health belongs in the type 2 diabetes conversation That question has become more urgent as […]
Earlier Risk Stratification in Diabetic Kidney Disease May Help Teams Target Care—What a New Real-World Study Shows
Kidney disease is one of the most serious complications associated with type 2 diabetes, yet it can progress quietly. A person may feel well while urine albumin changes, estimated glomerular filtration rate (eGFR) declines, blood pressure rises, or cardiovascular risk increases. That is why early screening and risk assessment matter. They give the care team […]
A Sorbitol Study Is Raising New Questions About Gut Microbes and Fatty Liver—But It Was Not a Human Trial
A headline about a “diabetic-friendly” sweetener harming the liver is designed to get attention. It can also leave people with type 2 diabetes wondering whether a piece of sugar-free gum, a product labeled “no sugar,” or fruit is suddenly dangerous. The honest answer is more useful than the alarming one: a new study raises an […]
Digital Diabetes Care Is Expanding Around GLP-1s. The Real Test Is Whether Support Extends Beyond the Prescription.
GLP-1 medicines are changing more than medication lists. They are changing the market for diabetes support. Employers, health plans, clinicians, and patients are all asking versions of the same question: if a person starts a GLP-1 medicine, what happens around the prescription? Who helps them understand side effects, protect nutrition, stay active, navigate coverage, monitor […]
Food Is Medicine Works Best When It Is Built Into Care—not Added as an Afterthought
“Food is medicine” is an appealing phrase because it names something many people living with type 2 diabetes already know: food choices are not a side note. They affect energy, glucose patterns, blood pressure, lipids, sleep, and the routines that make treatment sustainable. But the phrase can also become vague. Telling someone to “eat better” […]
A GLP-1 Prescription Is Not a Complete Care Plan: What Responsible Evaluation and Follow-Up Look Like
GLP-1 medicines have become a major part of conversations about weight, blood sugar, and metabolic health. That visibility has created opportunity: some people who once felt shut out of care are now asking better questions about diabetes, obesity, and long-term risk. It has also created a problem. A medication can be presented online as if […]
A One-Time Gene Therapy for Diabetic Retinopathy? What Is Known—and What Is Still Investigational
Diabetic retinopathy is a diabetes complication that affects the blood vessels of the retina, the light-sensitive tissue at the back of the eye. It can progress without noticeable symptoms in its early stages, which is why regular eye screening matters even when vision seems normal. A recent company announcement described follow-up results from a study […]
Akkermansia and Type 2 Diabetes: Promising Microbiome Science, Not a Supplement Prescription
The human gut contains a large and diverse community of microorganisms. Researchers are increasingly interested in how this ecosystem interacts with digestion, immune signaling, medications, body weight, and metabolic health. One bacterium that appears frequently in this research is Akkermansia muciniphila. Akkermansia lives in the mucus layer of the intestine and has been associated, in […]